ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

PLCO Data Confirm Importance Of Regular Colorectal Cancer Screening, NCI Says

July 25, 2003

Cooperative group Outreach Extended Three ears, Gets Extra $1 Million, Up to Four More Awards

October 28, 1983

Final Issue Of 1992

December 11, 1992

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

GM To Offer Three Awards of $1000,000 Each To Cancer Investigators

September 8, 1978